Feb 16, 2022
Medable, a virtual trials provider, bought LEO Innovation’s Denmark-Based Omhu, which focuses on developing technology to address skin conditions.
Loading...
seen from United Kingdom
seen from China
seen from Austria
seen from United States
seen from Argentina
seen from China
seen from China
seen from United States
seen from United Kingdom
seen from China
seen from Netherlands
seen from United Kingdom
seen from United Kingdom
seen from United States
seen from Netherlands
seen from China
seen from China
seen from Hong Kong SAR China
seen from Hong Kong SAR China
seen from United States
Medable, a virtual trials provider, bought LEO Innovation’s Denmark-Based Omhu, which focuses on developing technology to address skin conditions.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Medable Inc., a leading software provider for patient-centered clinical trials, today announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
Digital clinical trial platform Medable landed a whopping $304 million in a Series D funding round led by Blackstone Growth, Tiger Global and GSR ventures. Sapphire Ventures and WTI also participated.
Medable from ILLO
This is about to be the best sucker in the world. #medable #highlife #medicalmarijuana #420
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming